Organogenesis Holdings Inc (ORGO)
4.05
+0.03
(+0.75%)
USD |
NASDAQ |
Nov 22, 16:00
4.05
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Price: 4.05 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 4.08 | 4.21 | 4.01 | 4.05 | 857732.0 |
| Nov 21, 2024 | 4.00 | 4.085 | 3.95 | 4.02 | 755479.0 |
| Nov 20, 2024 | 4.07 | 4.155 | 3.902 | 3.97 | 763616.0 |
| Nov 19, 2024 | 3.95 | 4.105 | 3.884 | 4.08 | 702531.0 |
| Nov 18, 2024 | 3.90 | 4.08 | 3.76 | 3.94 | 1.114M |
| Nov 15, 2024 | 4.11 | 4.12 | 3.772 | 3.86 | 687109.0 |
| Nov 14, 2024 | 4.29 | 4.350 | 3.63 | 4.005 | 1.785M |
| Nov 13, 2024 | 3.85 | 4.57 | 3.73 | 4.43 | 2.498M |
| Nov 12, 2024 | 3.55 | 3.62 | 3.39 | 3.45 | 552549.0 |
| Nov 11, 2024 | 3.34 | 3.545 | 3.33 | 3.50 | 621349.0 |
| Nov 08, 2024 | 3.29 | 3.34 | 3.20 | 3.28 | 284262.0 |
| Nov 07, 2024 | 3.21 | 3.345 | 3.155 | 3.26 | 464300.0 |
| Nov 06, 2024 | 3.19 | 3.25 | 3.07 | 3.21 | 560593.0 |
| Nov 05, 2024 | 2.97 | 3.09 | 2.96 | 3.04 | 224394.0 |
| Nov 04, 2024 | 2.78 | 3.005 | 2.75 | 2.99 | 371751.0 |
| Nov 01, 2024 | 2.81 | 2.84 | 2.77 | 2.78 | 144497.0 |
| Oct 31, 2024 | 2.89 | 2.91 | 2.755 | 2.77 | 209947.0 |
| Oct 30, 2024 | 2.97 | 3.005 | 2.89 | 2.89 | 118014.0 |
| Oct 29, 2024 | 2.92 | 3.02 | 2.90 | 2.98 | 1.092M |
| Oct 28, 2024 | 2.85 | 2.98 | 2.85 | 2.95 | 905145.0 |
| Oct 25, 2024 | 2.90 | 2.91 | 2.79 | 2.80 | 161751.0 |
| Oct 24, 2024 | 2.93 | 2.93 | 2.82 | 2.87 | 180302.0 |
| Oct 23, 2024 | 3.07 | 3.09 | 2.87 | 2.89 | 156769.0 |
| Oct 22, 2024 | 3.10 | 3.15 | 3.055 | 3.10 | 166588.0 |
| Oct 21, 2024 | 3.14 | 3.18 | 3.09 | 3.11 | 262365.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.89
Minimum
Mar 24 2023
23.23
Maximum
May 03 2021
6.023
Average
3.885
Median
Price Benchmarks
| Plus Therapeutics Inc | 1.18 |
| Poseida Therapeutics Inc | 2.73 |
| NovaBay Pharmaceuticals Inc | 0.681 |
| Palatin Technologies Inc | 0.96 |
| iBio Inc | 2.64 |
Price Related Metrics
| PS Ratio | 1.182 |
| Price to Book Value | 1.928 |
| Price to Free Cash Flow | 138.20 |
| Earnings Yield | -1.59% |
| Market Cap | 536.93M |
| Operating PE Ratio | 53.60 |
| Normalized PE Ratio | 56.62 |